TomoTherapy Enters Australian Market with Purchase by Royal Brisbane & Women’s Hospital
TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that it is expanding into Australia and New Zealand. The company recently signed a distribution agreement with Nucletron Pty Ltd. and was awarded a contract by Queensland Health to supply the first TomoTherapy® treatment system in Australia to Royal Brisbane & Women’s Hospital. “Until now, we have not had the integrated technology to deliver IMRT treatments to our patients,” said Greg Rattray, assistant director of radiation therapy at the Hospital. “With the installation of the TomoTherapy system, we will be able to advance our capabilities to the leading edge of IG-IMRT treatments." (9 Feb 2010) Read more




